Literature DB >> 17917717

Mechanisms of carvedilol-induced [Ca2+] i rises and death in human hepatoma cells.

Jin-Shiung Cheng1, Chorng-Chih Huang, Chiang-Ting Chou, Chung-Ren Jan.   

Abstract

The effect of the cardiovascular drug carvedilol on cytosolic free Ca2+ concentrations ([Ca2+]i) and viability has not been explored in human hepatoma cells. This study examined whether carvedilol altered [Ca2+]i and caused cell death in HA59T cells. [Ca2+]i and cell viability were measured using the fluorescent dyes fura-2 and WST-1, respectively. Carvedilol at concentrations >or=1 microM increased [Ca2+]i in a concentration-dependent manner with an EC50 value of 20 microM. The Ca2+ signal was reduced partly by removing extracellular Ca2+. Carvedilol induced Mn2+ quench of fura-2 fluorescence, implicating Ca2+ influx. The Ca2+ influx was sensitive to La3+, econazole, nifedipine, and SKF96365. In Ca2+-free medium, after pretreatment with 1 muM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor), carvedilol-induced [Ca2+]i rises were abolished; and conversely, carvedilol pretreatment inhibited a major part of thapsigargin-induced [Ca2+]i rises. Inhibition of phospholipase C with 2 microM U73122 did not change carvedilol-induced [Ca2+]i rises. At concentrations between 1 and 50 microM, carvedilol killed cells in a concentration-dependent manner. The cytotoxic effect of 1 microM (but not 30 microM) carvedilol was fully reversed by prechelating cytosolic Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester (BAPTA/AM). Apoptosis was induced by 30 (but not 1) microM carvedilol. Collectively, in HA59T hepatoma cells, carvedilol induced [Ca2+]i rises by causing Ca2+ release from the endoplasmic reticulum in a phospholipase-C-independent manner and Ca2+ influx via store-operated Ca2+ channels. Carvedilol-caused cytotoxicity was mediated by Ca2+ and apoptosis in a concentration-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917717     DOI: 10.1007/s00210-007-0191-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  44 in total

1.  Calcium signalling: more messengers, more channels, more complexity.

Authors:  Martin D Bootman; Michael J Berridge; H Llewelyn Roderick
Journal:  Curr Biol       Date:  2002-08-20       Impact factor: 10.834

2.  A novel Ca2+-induced Ca2+ release mechanism mediated by neither inositol trisphosphate nor ryanodine receptors.

Authors:  Frank Wissing; Edmund P Nerou; Colin W Taylor
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Effect of NPC-14686 (Fmoc-L-homophenylalanine) on intracellular Ca2+ levels in human hepatoma cells.

Authors:  Chung-Ren Jan; Soong-Yu Kuo; Jin-Shiung Cheng; Yuk-Keung Lo; Chun-Peng Liu; Wei-Chung Chen
Journal:  Life Sci       Date:  2003-04-25       Impact factor: 5.037

Review 4.  Carvedilol: just another Beta-blocker or a powerful cardioprotector?

Authors:  R S Carreira; P Monteiro; L M Gon Alves; L A Providência
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2006-12

Review 5.  Carvedilol: use in chronic heart failure.

Authors:  Robert Neil Doughty; Harvey D White
Journal:  Expert Rev Cardiovasc Ther       Date:  2007-01

6.  Nifedipine block of capacitative calcium entry in cultured human uterine smooth-muscle cells.

Authors:  R C Young; R Schumann; P Zhang
Journal:  J Soc Gynecol Investig       Date:  2001 Jul-Aug

7.  Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.

Authors:  Paolo Spallarossa; Silvano Garibaldi; Paola Altieri; Patrizia Fabbi; Valeria Manca; Sabina Nasti; Pierfranco Rossettin; Giorgio Ghigliotti; Alberto Ballestrero; Franco Patrone; Antonio Barsotti; Claudio Brunelli
Journal:  J Mol Cell Cardiol       Date:  2004-10       Impact factor: 5.000

8.  Effect of nordihydroguaiaretic acid on intracellular Ca(2+) concentrations in hepatocytes.

Authors:  Jin-Shiung Cheng; Chung-Ren Jan
Journal:  Toxicol In Vitro       Date:  2002-10       Impact factor: 3.500

9.  Evidence that store-operated Ca2+ channels are more effective than intracellular messenger-activated non-selective cation channels in refilling rat hepatocyte intracellular Ca2+ stores.

Authors:  R B Gregory; D Sykiotis; G J Barritt
Journal:  Cell Calcium       Date:  2003-09       Impact factor: 6.817

10.  Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.

Authors:  Taka-Aki Koshimizu; Gozoh Tsujimoto; Akira Hirasawa; Yoko Kitagawa; Akito Tanoue
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

View more
  1 in total

1.  Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.

Authors:  Qian Ding; Xiang-Guo Tian; Yan Li; Qi-Zhi Wang; Chun-Qing Zhang
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.